Clinical Trials Directory

Trials / Completed

CompletedNCT07274800

Adjuvant Ultra-Hypofractionated vs Hypofractionated Radiotherapy for Early Breast Cancer

Adjuvant Ultra Hypofractionation Radiotherapy Versus Hypofractionation Radiotherapy in Treatment of Early Invasive Breast Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Zagazig University · Other Government
Sex
Female
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

breast-conserving surgery. One group receives ultra-hypofractionated radiotherapy (26 Gy in 5 sessions over 1 week), while the other group receives hypofractionated radiotherapy (40 Gy in 15 sessions over 3 weeks). The study aims to compare skin toxicity, cosmetic outcomes, and local cancer control between thetwo schedules . Participants are followed during and after radiotherapy for up to 24 months.

Conditions

Interventions

TypeNameDescription
RADIATIONAdjuvant Ultra hypofractionation radiotherapyAdjuvant external beam radiotherapy after breast-conserving surgery Total dose: 26 Gy delivered in 5 fractions over 1 week 3D conformal radiotherapy technique without breath-hold Daily fractionation, whole breast irradiation
RADIATIONAdjuvant Hypofarctionated radiotherapyAdjuvant external beam radiotherapy after breast-conserving surgery Total dose: 40 Gy delivered in 15 fractions over 3 week 3D conformal radiotherapy technique without breath-hold Daily fractionation, whole breast irradiation

Timeline

Start date
2023-11-27
Primary completion
2025-11-27
Completion
2025-11-27
First posted
2025-12-10
Last updated
2025-12-10

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07274800. Inclusion in this directory is not an endorsement.